Boston Scientific launches Axios stent and delivery system
Boston Scientific (NYSE:BSX) said today it launched its Axios stent and electrocautery delivery system which obtained through the $62.5 million buy of Xlumena, who produces the Axios line. The newly...
View ArticleDeviceTalks Podcast: Cohera Medical CEO Patrick Daly
Before Patrick Daly was tapped as chairman of AdvaMed’s Accel unit, which represents emerging medical device companies, the CEO of Cohera Medical sat down with MassDevice.com Executive Editor Brad...
View ArticleTitan Medical prices offering to support Sport robot system
Titan Medical (CVE:TMD) said today it priced a previously announced offering, planning to offer an unspecified number of shares priced at 77¢ (CDN $1) per unit, with each unit comprised of a common...
View ArticleIn Vitro Diagnostics – The Basics
It has been estimated that In Vitro Diagnostics (IVD) will play a role in around 70% of health care decisions, and market estimates predict the IVD market will be close to 75 billion dollars in 2010....
View ArticleAerin Medical closes $16.7m Series C
Nasal airflow device developer Aerin Medical said today it closed a $16.7 million Series C financing round which it operated in 2 separate stages. The company said an initial closing of $6.1 million...
View ArticleDozens sue Bayer over Essure permanent contraceptive implants
UPDATED March 23, 2016, with comment from Bayer. More than 30 women are suing Bayer (ETR:BAYN) over injuries allegedly related to its Essure permanent birth control device, claiming the device led to...
View ArticleMassDevice.com +5 | The top 5 medtech stories for March 22, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleEndeavour Vision shifts focus to medtech with new $275m fund
Healthcare investor Endeavour Vision said today it it will shift its focus to medtech after raising $275 million (€250 million) in committed capital for its Endeavour Medtech Growth LP fund. The firm...
View ArticleSanuwave Health brings in $1.5m for dermaPACE
Sanuwave Health (OTC:SNWV) said Monday it closed a $1.5 million round of equity financing to help support the FDA submission of Phase III clinical trial data to support the clearance of its dermaPACE...
View ArticleHow to win early investors: Tips for gauging startup resources
How do you get companies or investors to support your project in a startup world where “many are called, few are chosen?” Vector attended a panel last week on the subject, moderated by Ryan Dietz,...
View ArticleM3 medical portal, backed by Sony, gets into medical devices with MedTecHeart...
M3 Inc., a Sony (TYO:6758)-backed Japanese web portal for physicians, is getting into the medical device game with an investment in MedTecHeart and its outside-the-body cardiac assist device. A joint...
View ArticleTrial kicks off in 10-year-old Abbott stent case
A 10-year-old whistleblower lawsuit filed by a former Abbott (NYSE:ABT) sales rep, over the alleged off-label marketing of biliary stents, finally went to trial in Dallas yesterday. Plaintiff Kevin...
View ArticleStryker launches $5m SurgiCount liability plan for retained sponges
Stryker (NYSE:SYK) said today it is launching the SurgiCount Promise risk-sharing program, offering up to $5 million in product-liability costs to hospitals which use its SurgiCount safety-sponge...
View ArticlePhilips Respironics settles kickbacks case for $35m
The Respironics division at Philips (NYSE:PHG) agreed to pay $34.8 million to settle U.S. Justice Dept. claims that it paid kickbacks in the form of free call center services to induce suppliers into...
View ArticleFDA warns Terumo over vascular sheath
The FDA last week sent a warning letter to Terumo Corp. (TYO:4543) over issues with the manufacturing and quality control of its Destination Guiding vascular sheaths. The agency warned the company over...
View ArticleFDA clears Stimwave’s StimQ wireless chronic pain stimulator
Stimwave Technologies said today that it’s putting its StimQ peripheral nerve stimulator on the U.S. market after winning pre-market approval from the FDA earlier this month. The StimQ device is...
View ArticleAustralian ImpediMed raises $56m in private placement
Australian medtech developer ImpediMed said yesterday it closed a $56.6 million (AUD $75.1 million) private placement financing round. The company develops and distributes medical devices which use...
View ArticleSchein expands footprint in Japan with J. Morita stake
Henry Schein (NSDQ:HSIC) said it’s expanding its footprint in the Japanese dental market by buying a 50% stake in a subsidiary of J. Morita Corp. for an undisclosed amount. Melville, N.Y.-based Schein...
View ArticleFDA OKs improved MarginProbe device from Dune Medical
Dune Medical Devices said today it won pre-market approval from the FDA for modifications to its MarginProbe breast cancer surgical device designed for real-time detection of cancer in breast...
View ArticleMassDevice.com +5 | The top 5 medtech stories for March 23, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View Article
More Pages to Explore .....